ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 71 filers reported holding ALBIREO PHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $321,000 | -74.7% | 16,052 | -59.2% | 0.00% | -100.0% |
| Q2 2019 | $1,269,000 | +8.1% | 39,356 | +8.0% | 0.00% | 0.0% |
| Q1 2019 | $1,174,000 | +29.3% | 36,448 | -1.5% | 0.00% | 0.0% |
| Q4 2018 | $908,000 | -28.4% | 37,018 | -3.8% | 0.00% | 0.0% |
| Q3 2018 | $1,269,000 | +1.5% | 38,489 | +9.3% | 0.00% | 0.0% |
| Q2 2018 | $1,250,000 | – | 35,214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 491,244 | $9,510,000 | 5.10% |
| Decheng Capital Management III (Cayman), LLC | 623,342 | $12,068,000 | 4.38% |
| TANG CAPITAL MANAGEMENT LLC | 1,099,516 | $21,287,000 | 2.61% |
| Privium Fund Management B.V. | 300,252 | $5,624,000 | 2.04% |
| Birchview Capital, LP | 117,000 | $2,265,000 | 1.60% |
| Perceptive Advisors | 2,360,139 | $45,692,000 | 1.33% |
| Chicago Capital, LLC | 1,119,774 | $21,679,000 | 1.25% |
| Endurant Capital Management LP | 172,621 | $3,342,000 | 1.09% |
| Deep Track Capital, LP | 1,110,624 | $21,502,000 | 0.98% |
| SPHERA FUNDS MANAGEMENT LTD. | 359,000 | $6,950,000 | 0.96% |